Action Chad Therapeutics - CTU

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

CHAD Therapeutics Plans to Begin Trading on the OTC Bulletin Board

CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it plans to withdraw its common stock from the American Stock Exchange...

Dormio Tech Division of CHAD Therapeutics Receives FDA Clearance to Market Its FloCHANNEL Sleep Diagnostic Device

Dormio Tech, a division of CHAD Therapeutics, Inc. (AMEX:CTU), announced today that it received 510(K) clearance from the FDA to...

CHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing Requirements

CHAD Therapeutics, Inc. (AMEX:CTU) today announced that on July 23, 2008, it received a letter from the American Stock Exchange...

CHAD Therapeutics Reports Going Concern Qualification

CHAD Therapeutics, Inc. (AMEX:CTU) today reported that its independent registered accountants, Rose, Snyder & Jacobs, had...

CHAD Therapeutics Closes Sale of Transfilling Assets for $1.825 Million in Cash

CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has closed the sale of the assets related to its transfilling oxygen...

CHAD Therapeutics Closes Sale of Its Oxygen Business to INOVO

CHAD Therapeutics, Inc. (AMEX:CTU) announced that it has closed the sale of the assets related to CHAD's oxygen conserving...

CHAD Therapeutics Reports Third Quarter Results

CHAD Therapeutics, Inc. (AMEX:CTU) today announced operating results for the third quarter and first nine months of fiscal 2008...

CHAD Therapeutics Shareholders Approve Sale of Company's Oxygen Business to INOVO

Following a special meeting of shareholders held today, CHAD Therapeutics, Inc. (AMEX:CTU) announced that its shareholders have...

CHAD Therapeutics Announces Mailing of Definitive Proxy Regarding Proposed Sale of Its Oxygen Business

CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has commenced mailing its definitive proxy statement to shareholders...

CHAD Therapeutics Reports Fiscal 2008 First Quarter Results

CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the first quarter of fiscal 2008. First Quarter...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

CTU - Frequently Asked Questions (FAQ)

What is the current Chad Therapeutics share price?

The current share price of Chad Therapeutics is US$ 0,00

What is the 1 year trading range for Chad Therapeutics share price?

Chad Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
KNWKnow Labs Inc	US$ 2,222 (2 495,79%)	254,56k
MMAMixed Martial Arts Group Limited	US$ 0,80 (31,15%)	91,3k
SACHSachem Capital Corporation	US$ 1,33 (16,67%)	782,98k
ARMUT REX 2X Long ARM Daily Target ETF	US$ 27,08 (14,33%)	3,8k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 18,47 (11,33%)	33,35M
IBOImpact Biomedical Inc	US$ 0,93 (-23,14%)	42,42k
ATCHAtlasClear Holdings Inc	US$ 1,36 (-13,92%)	802,48k
GOROGold Resource Corporation	US$ 0,5213 (-13,12%)	10M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 6,0701 (-11,51%)	90,17M
LLYXDefiance Daily Target 2X Long LLY ETF	US$ 22,03 (-9,53%)	228,3k
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 20,88 (8,58%)	139,35M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6,69 (-1,47%)	121,41M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 6,0701 (-11,51%)	90,17M
XLFFinancial Select Sector	US$ 49,12 (-0,53%)	85,46M
SPYSPDR S&P 500	US$ 575,92 (0,56%)	80,19M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Chad Therapeutics, (CTU)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

CTU Dernières nouvelles

CHAD Therapeutics Plans to Begin Trading on the OTC Bulletin Board

Dormio Tech Division of CHAD Therapeutics Receives FDA Clearance to Market Its FloCHANNEL Sleep Diagnostic Device

CHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing Requirements

CHAD Therapeutics Reports Going Concern Qualification

CHAD Therapeutics Closes Sale of Transfilling Assets for $1.825 Million in Cash

CHAD Therapeutics Closes Sale of Its Oxygen Business to INOVO

CHAD Therapeutics Reports Third Quarter Results

CHAD Therapeutics Shareholders Approve Sale of Company's Oxygen Business to INOVO

CHAD Therapeutics Announces Mailing of Definitive Proxy Regarding Proposed Sale of Its Oxygen Business

CHAD Therapeutics Reports Fiscal 2008 First Quarter Results

CTU - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Chad Therapeutics, (CTU) Cours

Chad Therapeutics, (CTU)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

CTU Dernières nouvelles

CHAD Therapeutics Plans to Begin Trading on the OTC Bulletin Board

Dormio Tech Division of CHAD Therapeutics Receives FDA Clearance to Market Its FloCHANNEL Sleep Diagnostic Device

CHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing Requirements

CHAD Therapeutics Reports Going Concern Qualification

CHAD Therapeutics Closes Sale of Transfilling Assets for $1.825 Million in Cash

CHAD Therapeutics Closes Sale of Its Oxygen Business to INOVO

CHAD Therapeutics Reports Third Quarter Results

CHAD Therapeutics Shareholders Approve Sale of Company's Oxygen Business to INOVO

CHAD Therapeutics Announces Mailing of Definitive Proxy Regarding Proposed Sale of Its Oxygen Business

CHAD Therapeutics Reports Fiscal 2008 First Quarter Results

CTU - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE